Peripheral line for vasopressor administration: Prospective multicenter observational cohort study for survival and safety
PLOS One · 13.10.2025 · 20 (10) · e0333275
DOI: 10.1371/journal.pone.0333275 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift PLOS One, online erschienen am 13.10.2025. Verfasst von Adane Petros und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Addis Ababa University, College of Health Sciences, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Vasoconstrictor Agents, Catheterization, Peripheral, Shock. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Addis Ababa University College of Health Sciences.
Abstract (Originalsprache)
Background
The placement of a central venous catheter (CVC) is associated with a high risk of central line-related bacteremia and mechanical complications. In a resource-constrained environment, the use of CVC is limited as a result of the complexity of the procedure and the need for a trained expert to place it. There is scant evidence on the feasibility, outcome, and safety of administering vasopressors using a peripheral venous catheter (PVC). Hence, our study, which is the first of its kind, evaluated the survival outcome, predictors, and safety of vasoactive drug administration via peripheral intravenous access in patients with circulatory shock.
Methods
A prospective cohort study was conducted in the Emergency Department and ICU setting of selected public and private hospitals in Addis Ababa on selected 250 circulatory shock patients over 6 months for whom vasopressor was administered peripherally. Data was collected daily using ODK by study site coordinators and trained data collectors. Statistical analysis was done using STATA 14.1 using descriptive analysis, Kaplan Meir survival analysis, and cox regression analysis.
Results
The median (IQR) age of the participants was 48.5 (35, 62). From circulatory shock causes, septic and cardiogenic shock accounted for 69.6% and 22.0% respectively. There were 3 extravasation injuries from the 250 patients that occurred exclusively on patients that took vasopressor for more than 4 days yielding an event rate of 1.2% and 0.004/patient day. Mortality in circulatory shock patients is high with a 57.6% mortality rate in general and 67.8% in septic shock patients. A Cox regression analysis identified decreased baseline systolic blood pressure [AHR = 0.98; 95%CI: 0.95, 0.99], decreased urine output [AHR = 0.96; 95%CI: 0.93, 0.99], septic shock compared to cardiogenic shock [AHR = 0.48; 95%CI: 0.24, 0.94], and use vasopressor other than norepinephrine [AHR = 0.6; 95%CI: 0.39, 0.92] as independent predictors of death of circulatory shock patients with peripherally administered vasopressors.
Conclusion
Our study found that peripheral venous catheter use for vasopressor administration in circulatory shock was associated with a low extravasation rate (1.2%), with all events occurring after more than five days, indicating it might be a safe alternative to CVC for short-term use in resource-limited settings. Findings support cautious prolonged use and consideration of central access when therapy exceeds a few days. This calls for randomized controlled trials to compare the safety and efficacy of vasopressor administration by PVC versus CVC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Addis Ababa University, College of Health Sciences, Addis Ababa, Ethiopia.
- Department of Public Health, Werabe University, College of Health Sciences, Werabe, Ethiopia.
- Addis Ababa University, College of Health Sciences, School of Medicine, Addis Ababa, Ethiopia.
- East African Training Initiative, Addis Ababa, Ethiopia.
- Cardiac Center Ethiopia, Addis Ababa, Ethiopia.
ORCID-Profile: Kehabtimer Shiferaw Kotiso, Fitsum Assefa Gemechu, Andargew Yohannes, Eyob Kebede Etesa
Förderung
- Addis Ababa University College of Health Sciences
Zitieren
APA
Petros, A., Melkie, A., Kotiso, K. S., Kebede, D., Oljira, C. F., Assefa Gemechu, F., Yusuf, H., Abebe, S., Ashagre, A., Bekele, A., Yohannes, A., Etesa, E. K., Bedru, M., & Gebremariam, T. H. (2025). Peripheral line for vasopressor administration: Prospective multicenter observational cohort study for survival and safety. PLOS One, 20(10), e0333275. https://doi.org/10.1371/journal.pone.0333275
Vancouver
Petros A, Melkie A, Kotiso KS, Kebede D, Oljira CF, Assefa Gemechu F, et al. Peripheral line for vasopressor administration: Prospective multicenter observational cohort study for survival and safety. PLOS One. 2025;20(10):e0333275. doi:10.1371/journal.pone.0333275
BibTeX
@article{Petros2025,
author = {Petros, Adane and Melkie, Addisu and Kotiso, Kehabtimer Shiferaw and Kebede, Dawit and Oljira, Chala Fekadu and Assefa Gemechu, Fitsum and Yusuf, Hanan and Abebe, Sintayehu and Ashagre, Aschalew and Bekele, Amsalu and Yohannes, Andargew and Etesa, Eyob Kebede and Bedru, Mohammed and Gebremariam, Tewodros Haile},
title = {Peripheral line for vasopressor administration: Prospective multicenter observational cohort study for survival and safety},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {10},
pages = {e0333275},
doi = {10.1371/journal.pone.0333275}
}
EUVIMED